The federal government re-ignited a controversial proposal to give generic drug makers the power to unilaterally update product labels to reflect new safety information, a proposal that drew criticism ...

WASHINGTON, Feb 28 (Reuters) - Generic drugmakers are furiously campaigning against a proposed U.S. rule that would require them to change the prescribing information on their products if they receive ...

Shopping smart doesn’t mean sacrificing quality – sometimes the best deals hide in plain sight on store shelves. Generic products often deliver the same performance as their expensive counterparts, ...

(Reuters) - The U.S. Food and Drug Administration on Tuesday defended its proposal to require generic drugmakers to update the prescribing information on their products if they become aware of new ...